Significant Ownership of Martine A. Rothblatt
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Martine A. Rothblatt focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
CIK context first
Continue from Martine A. Rothblatt
Significant Ownership of Martine A. Rothblatt
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| UTHR | United Therapeutics Corporation | Common Stock, par value $.01 per share | 4% | $919,429,634 | -$323,930,240 | 1,725,721 | -26% | Martine A. Rothblatt | 30 Sep 2026 |
Schedules 13D/G Reported by Martine A. Rothblatt:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.